21 July 2017 in Annals of Hematology
27 January 2015 in American Journal of Hypertension
Previous autopsy studies suggested that a reduced nephron number is associated with increased risk of hypertension and chronic kidney disease. However, the significance of the nephron number estimated from a renal biopsy in patients with hypertensive nephrosclerosis (HNS) has not yet been elucidated. In this cross-sectional study, we examined the clinicopathological findings of biopsy-proven HNS patients with preserved renal function (estimated glomerular filtration rate ≥ 60ml/min/1.73 m2). The glomerular density (GD; the number of glomeruli per total renal cortical area) in biopsy specimens was evaluated as a surrogate of the nephron number. Renal biopsies from kidney transplant donors were used as healthy controls. A total of 58 HNS patients were enrolled. The GD value in the HNS patients was low compared with those in the kidney transplant donors (2.0 vs. 3.2 /mm2). These differences remained significant when globally sclerotic glomeruli were included in the calculation of the GD. Of note, the GD in HNS patients with overt proteinuria (≥1g/day) was significantly lower than that of HNS patients with mild proteinuria (<1g/day; 1.8 vs. 2.2/mm2, P = 0.014). In contrast, other histopathological parameters, including the severity of global glomerulosclerosis, interstitial fibrosis/tubular atrophy and arterial and arteriole lesions were comparable between the 2 HNS subgroups. In addition, the GD was identified as a factor that was associated with the amount of urinary protein excretion at biopsy, independent of other clinicopathological factors. These results suggest that a low GD is a renal histological characteristic of HNS patients, especially those with overt proteinuria.
3 August 2017 in Clinical and Experimental Nephrology
16 March 2019 in Clinical and Experimental Nephrology
A decrease in absolute numbers (abs.) of circulating dendritic cells (DCs) and recruitment into target organs has been reported, but whether the level of proteinuria associates with circulating DC abs. has not been clarified.
19 March 2025 in Kidney360
Key Points: Cardio-Ankle Vascular Index (CAVI) is a known predictor of cardiovascular events; however, few studies have considered kidney prognosis. CAVI at the time of kidney biopsy was independently associated with long-term kidney prognosis in patients without diabetes. The CAVI cutoff value at the time of kidney biopsy for predicting future eGFR decline of ≥30% or ESKD was 7.7. Background: The Cardio-Ankle Vascular Index (CAVI) is a noninvasive index of arterial stiffness that is independent of BP at the time of measurement. Although the role of CAVI as a predictor of cardiovascular events has been reported, few studies have considered kidney prognosis. This study investigated the association between CAVI and long-term kidney prognosis in patients with nondiabetic CKD who underwent kidney biopsy. Methods: This study was a longitudinal, observational, single-center study of patients with CKD stages 1–4 and follow-up ≥1 year who had CAVI measured at the time of kidney biopsy. The primary outcome was a 30% decline in the eGFR from baseline or ESKD. Results: Forty-six patients (mean age, 53 years; median eGFR, 61.5 ml/min per 1.73 m2; median follow-up period, 98 months) were enrolled. Eighteen patients achieved the primary outcome and a higher CAVI was significantly associated with this outcome. Multivariate analyses consistently identified CAVI as an independent factor associated with the outcome. Using receiver-operating characteristic curve analysis, the cutoff value for CAVI was 7.7 (sensitivity, 78%; specificity, 79%). Kaplan–Meier analysis showed significantly lower outcome-free survival in the CAVI ≥7.7 group than in the CAVI <7.7 group. No consistent trend was observed between kidney histopathology and CAVI. Conclusions: CAVI at the time of kidney biopsy is independently associated with long-term kidney prognosis in patients with nondiabetic CKD.